CEBPA and acute myeloid leukemia: To gain further insights into the impact of different mutational subtypes, in particular the spectrum of CEBPA bZIP mutations, a pooled primary data analysis was performed involving detailed sequencing data as well as clinical variables and treatment outcome from more than 1000 CEBPA mutant AML patients.